Schedule 13G ownership disclosure

Edgewise Therapeutics Inc

Common Stock · CUSIP: 28036F105

Event date: 2025-03-31

Filing-level shares
5,282,154
Percent of class
5.6%
  • JANUS HENDERSON GROUP PLC

    Shares: 5,282,154 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000160
Form type
SCHEDULE 13G/A
Filer
Edgewise Therapeutics, Inc.
CIK
CIK 1710072
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub